Trial Profile
An Open-label Study to Assess the Effect of JTT-751 as Iron Replacement Therapy in Patients with Iron Deficiency Anemia
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Ferric citrate (Primary)
- Indications Iron deficiency anaemia
- Focus Registrational; Therapeutic Use
- Sponsors Japan Tobacco
- 11 Jul 2018 New trial record